| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.2 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.2 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |